{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009772","form_type":"8-K","ticker":"LYRA","cik":"0001327273","company_name":"Lyra Therapeutics, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.819744+00:00","generated_at":"2026-05-16T10:47:53.821952+00:00","sec_items":["2.05","5.02","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"confidence":"high","headline":"Lyra suspends LYR-210 development, lays off nearly all staff; CEO/CFO become consultants","bullets":["Board approved plan to suspend LYR-210 development and reduce workforce affecting substantially all employees, effective Jan 12, 2026.","CEO Dr. Maria Palasis and CFO Jason Cavalier terminated; they signed consulting agreements with monthly fees of $78,125 and $55,555.50, respectively.","Cash and equivalents $22.1M as of Sep 30, 2025; expected runway extended to Q3 2026.","Engaged SSG Capital Advisors to explore strategic alternatives; no assurance of any transaction.","Positive ENLIGHTEN 2 Phase 3 data for LYR-210 (June 2025) but capital constraints force halt."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009772","json":"https://secwatch.observer/filing/0001193125-26-009772.json","markdown":"https://secwatch.observer/filing/0001193125-26-009772.md","text":"https://secwatch.observer/filing/0001193125-26-009772.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1327273/000119312526009772/0001193125-26-009772-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1327273/000119312526009772/d27712d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:47:53.821952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}